Review



anti cd19  (Bio X Cell)


Bioz Verified Symbol Bio X Cell is a verified supplier
Bioz Manufacturer Symbol Bio X Cell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Bio X Cell anti cd19
    Anti Cd19, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 76 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd19/InVivoMAb+anti-mouse+CD19/bio_rxiv__64898__2026__09__30__755684-206-18-23
    Average 95 stars, based on 76 article reviews
    anti cd19 - by Bioz Stars, 2026-11
    95/100 stars

    Images

    Related Articles

    Injection:

    Article Title: Use of CXCL13 binding molecules to promote peripheral nerve regeneration
    Article Snippet: Depletion of CD4 T cells was performed with the same regimen used for CD8 T cell depletion using InvivoMAb Anti-mouse CD4 (YTS 191, BioXcell, BE0119) and the isotype control of rat IgG2b. .. Aged mice were i.p. injected with the following antibody cocktail: 150 μg InvivoMAb Anti-mouse CD19 (1D3, BioXcell, BE0150), 150 μg InvivoMAb Anti-mouse B220 (RA3.3A1/6.1, BioXcell, BE0067), 150 μg InvivoMAb Anti-mouse CD22 (Cy34.1, BioXcell, BE0011). .. 48 hours later, the mice were injected with a secondary antibody InvivoMAb Anti-rat Kappa (MAR18.5, BioXcell, BE0122), at a dose of 150 μg per mouse.

    Article Title: Reversible CD8 T cell-neuron cross-talk causes aging-dependent neuronal regenerative decline.
    Article Snippet: Recombinant mouse IFN-g (10 mg, Biolegend, #575308) and 25%D-mannitol (200 ml, Sigma,M4125)were i.p. and i.v. injected, respectively, into each mouse 2 days before sciatic nerve crush. .. Aged mice were i.p. injected with antibody cocktail consisting of 150 mg of InvivoMAb anti-mouse CD19 (1D3, BioXcell, BE0150), 150 mg of InvivoMAb anti-mouse B220 (RA3.3A1/6.1, BioXcell, BE0067), and 150 mg of InvivoMAb anti-mouse CD22 (Cy34.1, BioXcell, BE0011). .. Forty-eight hours later, the mice were injected with a secondary antibody InvivoMAb anti-rat kappa (MAR18.5, BioXcell, BE0122), at a dose of 150 mg per mouse.

    other:

    Article Title: Divergent Role for STAT5 in the Adaptive Responses of Natural Killer Cells
    Article Snippet: InVivoMab Anti-Mouse CD19 (NK cell enrichment, clone 1D3) , Bio X Cell , Cat#BE0150; RRID: AB_10949187.

    Incubation:

    Article Title: Expanding the cytokine receptor alphabet reprograms T cells into diverse states
    Article Snippet: A20 cells were labelled with FarRed using the Invitrogen CellTrace Far Red Cell Proliferation Kit (Thermo Fisher Scientific) according to the manufacturer’s instructions. .. Labelled A20 cells (5 × 10 6 ) were then incubated with InVivoMAb anti-mouse CD19 (5 μg ml −1 , ID3, BioXCell) in 1.25 ml RPMI medium at 37 °C for 10 min. No-ICD o2R and oGCSFR-transduced pmel-1 CD8 + T cells were maintained in MSA–oIL-2 (500 nM) for 72 h. For the blocking experiment, T cells were pretreated with a blocking cocktail containing anti-mouse CD64 (BioLegend, X54-5/7.1) and anti-mouse CD16/32 (BioLegend, 93) at 1 μg ml −1 . ..

    Blocking Assay:

    Article Title: Expanding the cytokine receptor alphabet reprograms T cells into diverse states
    Article Snippet: A20 cells were labelled with FarRed using the Invitrogen CellTrace Far Red Cell Proliferation Kit (Thermo Fisher Scientific) according to the manufacturer’s instructions. .. Labelled A20 cells (5 × 10 6 ) were then incubated with InVivoMAb anti-mouse CD19 (5 μg ml −1 , ID3, BioXCell) in 1.25 ml RPMI medium at 37 °C for 10 min. No-ICD o2R and oGCSFR-transduced pmel-1 CD8 + T cells were maintained in MSA–oIL-2 (500 nM) for 72 h. For the blocking experiment, T cells were pretreated with a blocking cocktail containing anti-mouse CD64 (BioLegend, X54-5/7.1) and anti-mouse CD16/32 (BioLegend, 93) at 1 μg ml −1 . ..



    Similar Products

    95
    Bio X Cell anti cd19
    Anti Cd19, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd19/InVivoMAb+anti-mouse+CD19/bio_rxiv__64898__2026__09__30__755684-206-18-23
    Average 95 stars, based on 1 article reviews
    anti cd19 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Bio X Cell rat anti mouse cd19 igg2a
    Rat Anti Mouse Cd19 Igg2a, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd19/InVivoMAb+anti-mouse+CD19/pm40903592-576-4-9
    Average 95 stars, based on 1 article reviews
    rat anti mouse cd19 igg2a - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Bio X Cell clone 1d3
    Clone 1d3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd19/InVivoMAb+anti-mouse+CD19/10__1016_slash_j__ccell__2026__02__013-283-72-74
    Average 95 stars, based on 1 article reviews
    clone 1d3 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Bio X Cell invivomab rat igg2b antibody
    Invivomab Rat Igg2b Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd19/InVivoMAb+anti-mouse+CD19/pm41655210-312-42-46
    Average 95 stars, based on 1 article reviews
    invivomab rat igg2b antibody - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Bio X Cell invivomab anti mouse ctla 4 antibody
    Invivomab Anti Mouse Ctla 4 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd19/InVivoMAb+anti-mouse+CD19/pm41655210-312-26-30
    Average 95 stars, based on 1 article reviews
    invivomab anti mouse ctla 4 antibody - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Bio X Cell invivomab anti mouse cd19 antibody
    Invivomab Anti Mouse Cd19 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd19/InVivoMAb+anti-mouse+CD19/pm41655210-312-34-38
    Average 95 stars, based on 1 article reviews
    invivomab anti mouse cd19 antibody - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Bio X Cell anti mouse cd19
    VV-DDIL23 efficacy depends on CD4 + T cells mediated immune surveillance. ( A ) The schematic diagram represents the immune cell depleting experiment in mice beading pancreatic tumor by anti-CD4, anti-CD8, anti-NK1.1, or <t>anti-CD19</t> depletion antibodies, or IgG control. ( B ) Tumor growth curves in A . ( C ) Survival curves in A . ( D ) Representative histological images of tumor sections from the indicated groups in H. Red staining indicates Ki67 + cells; green staining indicates CD4 + cells. Scale bar=100 µm. ( E ) Quantification of data shown in D ) (n=3 for PBS, n=4 for VV-DD or VV-DDIL23). ( F ) Workflow for the pancreatic tumor modeling with tumor re-challenge. ( G ) Tumor growth curves after re-challenge (n=1 for VV-DD group, blue; n=6 for VV-DDIL23 group, yellow). ( H ) Representative flow cytometry plots of CD44 + CD62L − in CD4 + cells from spleen. ( I ) Percentage of CD44 + CD62L − subpopulations in CD4 + cells. Data are presented as mean±SEM. Statistical significance was determined by an unpaired two-tailed Student’s t-test for area under the curve ( B ) and Kaplan-Meier survival analysis with log-rank (Mantel-Cox) tests ( C ) and unpaired two-tailed Student’s t-tests ( E, I ). P values are indicated. i.t., intratumoral; ns, not significant; PBS, phosphate-buffered saline; s.c., subcutaneously.
    Anti Mouse Cd19, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd19/InVivoMAb+anti-mouse+CD19/pmc13630030-260-44-48
    Average 95 stars, based on 1 article reviews
    anti mouse cd19 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Bio X Cell cd19
    VV-DDIL23 efficacy depends on CD4 + T cells mediated immune surveillance. ( A ) The schematic diagram represents the immune cell depleting experiment in mice beading pancreatic tumor by anti-CD4, anti-CD8, anti-NK1.1, or <t>anti-CD19</t> depletion antibodies, or IgG control. ( B ) Tumor growth curves in A . ( C ) Survival curves in A . ( D ) Representative histological images of tumor sections from the indicated groups in H. Red staining indicates Ki67 + cells; green staining indicates CD4 + cells. Scale bar=100 µm. ( E ) Quantification of data shown in D ) (n=3 for PBS, n=4 for VV-DD or VV-DDIL23). ( F ) Workflow for the pancreatic tumor modeling with tumor re-challenge. ( G ) Tumor growth curves after re-challenge (n=1 for VV-DD group, blue; n=6 for VV-DDIL23 group, yellow). ( H ) Representative flow cytometry plots of CD44 + CD62L − in CD4 + cells from spleen. ( I ) Percentage of CD44 + CD62L − subpopulations in CD4 + cells. Data are presented as mean±SEM. Statistical significance was determined by an unpaired two-tailed Student’s t-test for area under the curve ( B ) and Kaplan-Meier survival analysis with log-rank (Mantel-Cox) tests ( C ) and unpaired two-tailed Student’s t-tests ( E, I ). P values are indicated. i.t., intratumoral; ns, not significant; PBS, phosphate-buffered saline; s.c., subcutaneously.
    Cd19, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd19/InVivoMAb+anti-mouse+CD19/bio_rxiv__2025__09__26__678857-145-30-36
    Average 95 stars, based on 1 article reviews
    cd19 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    Image Search Results


    VV-DDIL23 efficacy depends on CD4 + T cells mediated immune surveillance. ( A ) The schematic diagram represents the immune cell depleting experiment in mice beading pancreatic tumor by anti-CD4, anti-CD8, anti-NK1.1, or anti-CD19 depletion antibodies, or IgG control. ( B ) Tumor growth curves in A . ( C ) Survival curves in A . ( D ) Representative histological images of tumor sections from the indicated groups in H. Red staining indicates Ki67 + cells; green staining indicates CD4 + cells. Scale bar=100 µm. ( E ) Quantification of data shown in D ) (n=3 for PBS, n=4 for VV-DD or VV-DDIL23). ( F ) Workflow for the pancreatic tumor modeling with tumor re-challenge. ( G ) Tumor growth curves after re-challenge (n=1 for VV-DD group, blue; n=6 for VV-DDIL23 group, yellow). ( H ) Representative flow cytometry plots of CD44 + CD62L − in CD4 + cells from spleen. ( I ) Percentage of CD44 + CD62L − subpopulations in CD4 + cells. Data are presented as mean±SEM. Statistical significance was determined by an unpaired two-tailed Student’s t-test for area under the curve ( B ) and Kaplan-Meier survival analysis with log-rank (Mantel-Cox) tests ( C ) and unpaired two-tailed Student’s t-tests ( E, I ). P values are indicated. i.t., intratumoral; ns, not significant; PBS, phosphate-buffered saline; s.c., subcutaneously.

    Journal: Journal for Immunotherapy of Cancer

    Article Title: IL-23-engineered oncolytic vaccinia virus enhances pancreatic cancer control through inflammasome-driven Th17-skewed CD4+ T-cell responses

    doi: 10.1136/jitc-2026-016326

    Figure Lengend Snippet: VV-DDIL23 efficacy depends on CD4 + T cells mediated immune surveillance. ( A ) The schematic diagram represents the immune cell depleting experiment in mice beading pancreatic tumor by anti-CD4, anti-CD8, anti-NK1.1, or anti-CD19 depletion antibodies, or IgG control. ( B ) Tumor growth curves in A . ( C ) Survival curves in A . ( D ) Representative histological images of tumor sections from the indicated groups in H. Red staining indicates Ki67 + cells; green staining indicates CD4 + cells. Scale bar=100 µm. ( E ) Quantification of data shown in D ) (n=3 for PBS, n=4 for VV-DD or VV-DDIL23). ( F ) Workflow for the pancreatic tumor modeling with tumor re-challenge. ( G ) Tumor growth curves after re-challenge (n=1 for VV-DD group, blue; n=6 for VV-DDIL23 group, yellow). ( H ) Representative flow cytometry plots of CD44 + CD62L − in CD4 + cells from spleen. ( I ) Percentage of CD44 + CD62L − subpopulations in CD4 + cells. Data are presented as mean±SEM. Statistical significance was determined by an unpaired two-tailed Student’s t-test for area under the curve ( B ) and Kaplan-Meier survival analysis with log-rank (Mantel-Cox) tests ( C ) and unpaired two-tailed Student’s t-tests ( E, I ). P values are indicated. i.t., intratumoral; ns, not significant; PBS, phosphate-buffered saline; s.c., subcutaneously.

    Article Snippet: Beginning 1 day prior to virotherapy (day −1), mice received intraperitoneal depletion antibodies two times a week: 200 μg per dose of anti-mouse CD4 (clone GK1.5, Bio X Cell), anti-mouse CD8α (clone TIB-210, Bio X Cell), anti-mouse NK1.1 (clone PK136, Bio X Cell), and anti-mouse CD19 (clone 1D3, Bio X Cell).

    Techniques: Immune Cell, Control, Staining, Flow Cytometry, Two Tailed Test, Analysis, Saline